Boston Scientific acquires Penumbra
Boston Scientific agreed to acquire Penumbra. Reported deal value: $14.5B. Status: Announced. Sector: Technology. Target headquarters context: Alameda, California, United States.
This page summarizes publicly available information about the transaction as of 2026-01-15. Figures and status may change as filings and press coverage update.
Boston Scientific Corporation and Penumbra , Inc. , today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock transaction that values Penumbra at $374 per share, reflecting an enterprise value of approximately $14.5 billion
Deal timeline
This transaction is classified in Technology with a reported deal value of $14.5B. Figures and status may change as sources update.